Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Community-Acquired Pneumonia
100%
Pneumonia
54%
Intensive Care Unit
27%
Pathogen
22%
Infectious Disease
16%
Chronic Obstructive Pulmonary Disease
15%
Etiology
15%
Ventilator-Associated Pneumonia
14%
Antibiotic Therapy
14%
Prevalence
14%
Infection
13%
Artificial Respiration
13%
Antibiotics
13%
Diseases
12%
Streptococcus Pneumonia
12%
Pneumococcal Pneumonia
11%
Antimicrobial Therapy
11%
Empirical evidence
10%
Corticosteroid
10%
Antimicrobial Agent
10%
Patient with Pneumonia
10%
Macrolide
9%
Pseudomonas aeruginosa
9%
Bronchiectasis
9%
Lung
9%
COVID-19
8%
Observational Study
8%
Veterans Affairs
8%
Methicillin Resistant Staphylococcus Aureus
8%
Coughing
7%
Morbidity
7%
Systematic Review
7%
Sepsis
7%
Odds Ratio
7%
Elderly Patient
7%
Retrospective Cohort Study
6%
Intensive Care Medicine
6%
Cohort Analysis
6%
Antiinfective Agent
6%
Lung Transplantation
6%
Antibiotic Resistance
5%
Gram-Negative Bacteria
5%
Health Care Associated Pneumonia
5%
Mortality Rate
5%
Thorax Radiography
5%
Disease Severity
5%
Immunocompromised Patient
5%
Outpatient
5%
Necroptosis
5%
Chronic Cough
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pneumonia
47%
Community Acquired Pneumonia
47%
Chronic Obstructive Lung Disease
18%
Corticosteroid
14%
Antibiotics
13%
Diseases
13%
Cohort Study
12%
Antibiotic Therapy
11%
Antimicrobial Agent
11%
Infection
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Macrolide
8%
Ventilator Associated Pneumonia
8%
Pseudomonas aeruginosa
6%
Antiinfective Agent
6%
Prevalence
6%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Streptococcus Pneumonia
5%
Coughing
5%
Morbidity
5%
Sepsis
5%
Nursing and Health Professions
Community Acquired Pneumonia
24%
Intensive Care Unit
20%
Pneumonia
15%
Ventilator-Associated Pneumonia
11%
Practice Guideline
7%
Sepsis
7%
Diseases
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Antibiotic Therapy
5%
COVID-19
5%
Artificial Respiration
5%
Length of Stay
5%
Cohort Analysis
5%
